An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
The bactericidal effect of a new quinolone, ofloxacin (OFLO), was determined on an established Mycobacterium leprae infection in nude mice. Various drug regimens, including combinations of drugs, were examined for different treatment periods. OFLO and rifampin (RMP) individually failed to produce significant killing after treatment with a single large dose. However, when single large doses of OFLO and RMP were given in combination, a 100-fold reduction in viability was achieved. For a longer period of treatment both of these drugs, at lower doses, produced a moderate reduction in viability. The addition of dapsone to the lower dose of OFLO resulted in a significant reduction in viability, while lower doses of RMP and OFLO together produced a moderate reduction in viability.
Banerjee
D K
DK
Department of Medical Microbiology, St. George's Hospital Medical School, London, U.K.
McDermott-Lancaster
R D
RD
D000818:Animals; D003622:Dapsone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D008819:Mice, Nude; D009166:Mycobacterium leprae; D015242:Ofloxacin / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use; D015610:Serum Bactericidal Test
D003622:Dapsone; D015242:Ofloxacin; D012293:Rifampin